MedTrace Logo

VenaTech Convertible Vena Cava Filter U.S. Multi-Center Clinical Trial

NCT01112917 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 149

Last updated 2016-07-11

Study results available
· View outcomes & findings →

Summary

The investigation is designed to verify that clinical use of the vena cava filter does not raise new questions of safety or effectiveness compared to currently-marketed permanent filters.

Conditions

Interventions

DEVICE

VenaTech Convertible Vena Cava Filter

Prevention of Pulmonary Embolism

PROCEDURE

Vena Cava Filter Conversion

Conversion of VenaTech Convertible filter to open configuration.

Sponsors & Collaborators

  • Bright Research Partners

    collaborator INDUSTRY

  • NAMSA

    collaborator OTHER

  • B. Braun Interventional Systems, Inc

    lead INDUSTRY

Principal Investigators

  • William S Rilling, MD · Froedtert Hospital

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01112917 on ClinicalTrials.gov